Grégory Porras

2.3k total citations
33 papers, 1.6k citations indexed

About

Grégory Porras is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Grégory Porras has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 21 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Grégory Porras's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Grégory Porras is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neuroscience and Neuropharmacology Research (17 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Grégory Porras collaborates with scholars based in France, China and Italy. Grégory Porras's co-authors include Erwan Bézard, Philippe De Deurwaerdère, Umberto Spampinato, Évelyne Doudnikoff, Amandine Berthet, Elsa Y. Pioli, Qin Li, Sylvia Navailles, Bertrand Bloch and Sandra Doveró and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Grégory Porras

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grégory Porras France 20 1.1k 718 514 177 140 33 1.6k
Graziella Madeo Italy 20 761 0.7× 654 0.9× 309 0.6× 170 1.0× 104 0.7× 39 1.2k
Leonid Yavich Finland 19 779 0.7× 532 0.7× 298 0.6× 262 1.5× 163 1.2× 35 1.3k
Giuseppe Sciamanna Italy 25 1.4k 1.2× 1.1k 1.5× 485 0.9× 266 1.5× 77 0.6× 49 1.8k
Christophe Melon France 24 1.3k 1.1× 571 0.8× 543 1.1× 234 1.3× 153 1.1× 46 1.8k
Ilse S. Pienaar United Kingdom 22 618 0.6× 616 0.9× 559 1.1× 168 0.9× 173 1.2× 46 1.5k
Pascal Salin France 30 1.6k 1.4× 1.1k 1.5× 642 1.2× 232 1.3× 92 0.7× 83 2.2k
Mahmoud M. Iravani United Kingdom 26 1.0k 0.9× 854 1.2× 388 0.8× 182 1.0× 191 1.4× 55 1.7k
Michael F. Salvatore United States 24 1.1k 1.0× 699 1.0× 439 0.9× 196 1.1× 213 1.5× 58 1.7k
Sylvia Navailles France 24 1.3k 1.2× 650 0.9× 522 1.0× 226 1.3× 78 0.6× 40 1.7k
Antonella Pèzzola Italy 25 1.1k 1.0× 473 0.7× 641 1.2× 124 0.7× 129 0.9× 64 1.8k

Countries citing papers authored by Grégory Porras

Since Specialization
Citations

This map shows the geographic impact of Grégory Porras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégory Porras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégory Porras more than expected).

Fields of papers citing papers by Grégory Porras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégory Porras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégory Porras. The network helps show where Grégory Porras may publish in the future.

Co-authorship network of co-authors of Grégory Porras

This figure shows the co-authorship network connecting the top 25 collaborators of Grégory Porras. A scholar is included among the top collaborators of Grégory Porras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégory Porras. Grégory Porras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doveró, Sandra, Mathieu Bourdenx, Marie-Laure Arotçarena, et al.. (2023). Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain. npj Parkinson s Disease. 9(1). 135–135. 6 indexed citations
2.
Yu, Xuan, Ling Zhang, Wenjie Zhao, et al.. (2021). Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE. Heliyon. 7(2). e06302–e06302. 7 indexed citations
3.
Baufreton, Jérôme, Tomislav Milekovic, Qin Li, et al.. (2018). Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism. Movement Disorders. 33(10). 1632–1642. 13 indexed citations
4.
Bézard, Erwan, Ana Muñoz, Elisabetta Tronci, et al.. (2013). Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neuroscience Research. 77(4). 242–246. 38 indexed citations
5.
Bastide, Matthieu F., Sandra Doveró, Grégory Porras, et al.. (2013). Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia. Neurobiology of Disease. 62. 179–192. 61 indexed citations
6.
Berthet, Amandine, Erwan Bézard, Grégory Porras, et al.. (2012). l-DOPA Impairs Proteasome Activity in Parkinsonism through D1Dopamine Receptor. Journal of Neuroscience. 32(2). 681–691. 29 indexed citations
7.
Porras, Grégory, Amandine Berthet, Benjamin Dehay, et al.. (2012). PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking. Journal of Clinical Investigation. 122(11). 3977–3989. 101 indexed citations
8.
Doudnikoff, Évelyne, Antoine O. Berthet, Grégory Porras, et al.. (2011). Endogenous morphine-like compound immunoreactivity increases in parkinsonism. Brain. 134(8). 2321–2338. 25 indexed citations
9.
Ahmed, M. Rafiuddin, Amandine Berthet, Э.Р. Бычков, et al.. (2010). Lentiviral Overexpression of GRK6 Alleviates l -Dopa–Induced Dyskinesia in Experimental Parkinson’s Disease. Science Translational Medicine. 2(28). 28ra28–28ra28. 107 indexed citations
10.
Barraud, Quentin, Ibrahim Obeid, Incarnation Aubert, et al.. (2010). Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate. PLoS ONE. 5(10). e13306–e13306. 77 indexed citations
11.
Berthet, Amandine, Grégory Porras, Évelyne Doudnikoff, et al.. (2009). Pharmacological Analysis Demonstrates Dramatic Alteration of D1Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia. Journal of Neuroscience. 29(15). 4829–4835. 117 indexed citations
12.
Scheller, D., Hermann Lübbert, Grégory Porras, et al.. (2008). Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease. Neuroscience Letters. 432(1). 30–34. 24 indexed citations
13.
Gold, Stephen J., Grégory Porras, Elsa Y. Pioli, et al.. (2007). RGS9–2 Negatively Modulates l-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease. Journal of Neuroscience. 27(52). 14338–14348. 97 indexed citations
14.
Bézard, Erwan, et al.. (2007). 2.502 RGS9−2 negatively modulates L-dopa-induced dyskinesia in experimental Parkinson's disease. Parkinsonism & Related Disorders. 13. S143–S143. 1 indexed citations
15.
Porras, Grégory & Erwan Bézard. (2007). Preclinical development of gene therapy for Parkinson's disease. Experimental Neurology. 209(1). 72–81. 16 indexed citations
16.
Fernandez, Francesca, Grégory Porras, Pierre Mormède, Umberto Spampinato, & Francis Chaouloff. (2003). Effects of 3,4-methylenedioxymethamphetamine on locomotor activity and extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats. Neuroscience Letters. 335(3). 212–216. 8 indexed citations
18.
Porras, Grégory, Vincenzo Di Matteo, Philippe De Deurwaerdère, Ennio Esposito, & Umberto Spampinato. (2002). Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology. 43(7). 1099–1109. 37 indexed citations
19.
Lucas, Guillaume, Vincenzo Di Matteo, Philippe De Deurwaerdère, et al.. (2001). Neurochemical and electrophysiological evidence that 5‐HT4 receptors exert a state‐dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. European Journal of Neuroscience. 13(5). 889–898. 43 indexed citations
20.
Lucas, Guillaume, Philippe De Deurwaerdère, Grégory Porras, & Umberto Spampinato. (2000). Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology. 39(11). 1984–1995. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026